Breast Screening

Q&As to Support Patients

Some women are at higher risk of breast cancer because they have received radiotherapy above the waist to treat Hodgkin lymphoma when aged between 10 and 35 years old. These women should be referred to annual breast cancer MRI screening, starting 8 to 15 years after their treatment depending on their age. This is because the increased risk does not emerge until approximately 10 years later.

 

This advice came from the Chief Medical Officer in 2003, who also advised that all women who had this type of radiotherapy between 1962 and 2003 should be invited for an annual MRI. Depending on their age they should also have been offered a mammogram.

 

Last year, NHS England was alerted that some women were not receiving the level of screening that they need. After a thorough review of each patient record, the NHS is now contacting everyone affected to let them know, and to offer appropriate follow up care and support.

In 2003, some women were identified as being at increased risk of breast cancer, so were contacted by their local Trust to discuss their risks and were offered appropriate screening. A recent review by NHS clinicians showed that some of the women eligible for very high risk annual screening were not invited.

Last year, NHS England was alerted to the issue and carried out detailed investigations into each patient record to identify what action is needed.

Why am I being informed now? Last year, NHS England was alerted to the issue and a detailed investigation had to be carried out into each person’s record to understand their circumstances. This review found that some people were already on the right screening pathway, some were not eligible and some needed to be invited onto the very high risk screening pathway. Now the review is complete, patients are being quickly contacted.

If you are one of those who needs very high risk screening, the NHS will contact you and your local breast screening service will offer you an appointment for an MRI scan within three months. We will also check if you need a mammogram and if so, you will be offered that on the same day as your MRI.

For women who are considered at very high risk of breast cancer or for those with very dense breast tissue, an MRI is a more sensitive test as it can provide a very detailed image of your breast. Because you are considered at high risk of getting breast cancer, you are being offered MRI. You may also be offered a mammography at the same appointment, depending on your age and when you had your last one.

Copyright © NHS England 2024 6

A mammogram taken within the past 6 months, regardless of its setting (screening, symptomatic or private), does not need to be repeated and should be available to review alongside the MRI.

As part of the detailed review, while it can’t be determined with certainty whether it would have changed outcomes, NHS Trusts are committed to trying to contact families of patients that died of breast cancer to offer an apology and full discussion about not being on the very high risk pathway .

If cancer is found as part of the screening, your clinician will talk you through the options available and begin the treatment process.

If you would like to seek legal advice, you may wish to review the information available from NHS Resolution in the first instance Advice for claimants - NHS Resolution.

Radiotherapy Q&As

Radiotherapy is a very effective treatment for many cancers but like all treatments has some unwanted side effects, including second cancers. Girls and young women (aged 10-35 years) who receive radiotherapy to the chest involving breast tissue are at increased risk of developing breast cancer later in life.

 

Breast screening with mammography and/or MRI (magnetic resonance imaging) is effective at detecting breast cancers when small and potentially curable, which is why it is recommended, starting between 8-15 years after radiotherapy. Screening doesn’t start immediately after completion of radiotherapy because the increased risk doesn’t emerge until approximately 10 years later.

 

Screening for other second cancers isn’t currently recommended but work is underway to see if there is sufficient evidence to introduce this in some circumstances.

This refers to the type of radiotherapy that was used during this time window to treat patients with Hodgkin lymphoma. This technique delivered the radiotherapy to a large area of the neck, chest and upper body. However, it has since become much less frequently used.

No, radiotherapy is used to treat Hodgkin lymphoma in both males and females. The risk of a man developing a breast cancer following radiotherapy to their chest area when aged <35 years is low. This means that you do not need to have annual screening.

 

Also, breast screening has not been shown to be beneficial, even in men at high risk such as due to inherited genes, and so is not recommended by international guidelines.

Scroll to Top